Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Classifying Cancers Based on T-cell Infiltration and PD-L1
Long-term follow-up of patients with acute myelogenous leukemia receiving an autologous telomerase-based dendritic cell vaccine.
Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer.
Phase II randomized trial of autologous tumor lysate dendritic cell vaccine (ADC) plus best supportive care (BSC) compared with BSC, in pre-treated advanced colorectal cancer patients.
Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.
Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future
Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901
Gastric cancer and the epoch of immunotherapy approaches
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
Advances in the understanding of cancer immunotherapy
Vaccine immunotherapy in lung cancer: Clinical experience and future directions
Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer